MDK(SH:688079)2021-10-26 16:00Financial Performance - The company's operating revenue for Q3 2021 was ¥109,620,351.10, a decrease of 0.42% compared to the same period last year[5]. - Net profit attributable to shareholders for Q3 2021 was ¥23,687,495.70, down 39.71% year-on-year[5]. - The basic earnings per share for Q3 2021 was ¥0.06, a decline of 60.65% compared to the same period last year[6]. - The net profit attributable to shareholders for the year-to-date period decreased by 34.87% to ¥71,185,454.48[5]. - The net profit attributable to shareholders of the parent company for Q3 2021 was CNY 71,185,454.48, a decrease of 34.8% compared to CNY 109,304,803.82 in Q3 2020[23]. - The total operating profit for Q3 2021 was CNY 75,690,722.85, down 37.7% from CNY 121,460,735.58 in Q3 2020[22]. - The company reported a total comprehensive income of CNY 71,288,377.75 for Q3 2021, down from CNY 107,220,516.37 in Q3 2020, indicating a decline of 33.5%[23]. - The diluted earnings per share for Q3 2021 was CNY 0.19, compared to CNY 0.33 in Q3 2020, representing a decrease of 42.4%[24]. Research and Development - Research and development expenses totaled ¥16,443,464.00 in Q3 2021, an increase of 69.89% year-on-year, representing 15.00% of operating revenue[6]. - The company is focusing on enhancing new product and technology development, which has led to increased R&D expenses[10]. - Research and development expenses for the current period increased by 69.89% year-on-year, mainly due to higher total salaries for R&D personnel and the addition of multiple new R&D projects[11]. - Research and development expenses from the beginning of the year to the end of the reporting period increased by 57.00% year-on-year, driven by increased salaries and new R&D projects[11]. - Research and development expenses for Q3 2021 amounted to CNY 46,962,860.33, which is a 56.8% increase compared to CNY 29,913,387.46 in Q3 2020[22]. Assets and Liabilities - Total assets at the end of Q3 2021 reached ¥1,830,081,747.39, reflecting a growth of 69.29% compared to the end of the previous year[6]. - Current assets totaled ¥845,952,747.62, significantly higher than ¥267,541,274.86 in the previous year, marking a 215.5% increase[18]. - The company's total liabilities decreased to ¥256,339,910.45 from ¥479,536,135.45, a reduction of approximately 46.5%[19]. - Non-current assets totaled ¥984,128,999.77, up from ¥813,471,965.04, indicating a growth of 20.9%[18]. - The company reported a decrease in short-term borrowings to ¥7,008,739.73 from ¥115,856,904.41, a decline of approximately 93.9%[18]. - The equity attributable to shareholders increased by 168.04% year-on-year, amounting to ¥1,550,638,445.82[6]. - The equity attributable to shareholders increased to ¥1,550,638,445.82, up from ¥578,499,839.52, representing a growth of 168.5%[19]. - Cash and cash equivalents rose to ¥401,793,405.12 from ¥76,013,901.61, a substantial increase of 428.5%[17]. - The cash and cash equivalents at the end of Q3 2021 were CNY 401,793,405.12, significantly higher than CNY 39,085,940.69 at the end of Q3 2020, showing an increase of 927.5%[26]. Operating Activities - The company reported a cash flow from operating activities of ¥144,176,438.28, an increase of 22.15% year-to-date[6]. - The net cash flow from operating activities for the first three quarters of 2021 was CNY 144,176,438.28, up from CNY 118,027,630.27 in the previous year, reflecting a growth of 22.2%[25]. - The total revenue from operating activities for the first three quarters of 2021 was CNY 657,287,373.99, an increase of 34.2% from CNY 489,972,072.97 in the same period of 2020[25]. Operating Costs and Margins - Operating costs rose to ¥239,948,201.47 from ¥196,726,807.07, indicating an increase of 21.9%[21]. - The company has experienced a decline in gross margin due to changes in the sales revenue mix of various products[10]. - The company's total liabilities increased, with a significant rise in financial expenses, including interest expenses of CNY 1,534,701.63 for Q3 2021[22].